Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000167 · ClinicalTrials.gov registry record · Phase 3
Complications of Age-Related Macular Degeneration Prevention Trial
A Phase 3 study, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- Phase 3
- Development phase
- 1,052
- Enrollment target
NCT00000167: Completed Phase 3 study, sponsored by National Eye Institute (NEI).
NCT00000167 is a Phase 3 study that has completed, run by National Eye Institute (NEI). The registered enrollment target is 1,052 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (36% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000167, a Phase 3 study, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,052 participants
- Enrollment target
Study Summary
To determine whether application of low-intensity laser treatment of eyes with drusen in the macula can prevent later complications of age-related macular degeneration and thereby preserve visual function.
Interventions
- PROCEDURE Low-Intensity Laser Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,052 participants |
| Start Date | 1999-05 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
What the finished NCT00000167 record still lists
NCT00000167 is an interventional study that assigns participants to a tested intervention. Its 1,052 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (36% higher).
The record links to 0 conditions, and to 1 intervention - of which Low-Intensity Laser Treatment is the first listed.
NCT00000167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000167 about?
NCT00000167 is a clinical study titled "Complications of Age-Related Macular Degeneration Prevention Trial". To determine whether application of low-intensity laser treatment of eyes with drusen in the macula can prevent later complications of age-related macular degeneration and thereby preserve visual function.
What is the current status of trial NCT00000167?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,052 participants. The study started on 1999-05. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00000167?
The interventions under investigation include: Low-Intensity Laser Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00000167?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000167's enrollment target sits among peer trials
1,052 278th of 2000 higher than 1,720 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia